1 Benchmarking sets for molecular docking
来源：J MED CHEM( P 0022-2623 E 1520-4804 ) 发表时间: 2006/11
类型：期刊论文 为本人加分：35715.226616
贡献度：单独第一作者
2 Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through F..
来源：SCI TRANSL MED( P 1946-6234 E 1946-6242 ) 发表时间: 2019/04
类型：期刊论文 为本人加分：7490.016444
3 Molecular mechanics methods for predicting protein-ligand binding
来源：PHYS CHEM CHEM PHYS( P 1463-9076 E 1463-9084 ) 发表时间: 2006/01
类型：期刊论文 为本人加分：6193.478387
4 Binding-Site Assessment by Virtual Fragment Screening
来源：PLOS ONE( P 1932-6203 E ) 发表时间: 2010/04
类型：期刊论文 为本人加分：5849.364142
5 Exploiting ordered waters in molecular docking
来源：J MED CHEM( P 0022-2623 E ) 发表时间: 2008/08
类型：期刊论文 为本人加分：5548.371545
6 A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries
来源：CELLS-BASEL( P E 2073-4409 ) 发表时间: 2020/01
类型：期刊论文 为本人加分：5260.998471
7 Predicting or Pretending: Artificial Intelligence for Protein-Ligand Interactions Lack of Sufficient..
来源：FRONT PHARMACOL( P E 1663-9812 ) 发表时间: 2020/02
类型：期刊论文 为本人加分：5222.451064
8 A survey of the role of nitrile groups in protein-ligand interactions
来源：FUTURE MED CHEM( P 1756-8919 E 1756-8927 ) 发表时间: 2018/12
类型：期刊论文 为本人加分：4993.460267
9 Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptor..
来源：J MED CHEM( P 0022-2623 E 1520-4804 ) 发表时间: 2012/06
类型：期刊论文 为本人加分：4828.091632
10 Physics-based scoring of protein-ligand complexes: Enrichment of known inhibitors in large-scale vir..
来源：J CHEM INF MODEL( P 1549-9596 E 1549-960X ) 发表时间: 2006/01
类型：期刊论文,会议论文 为本人加分：4713.882053